Regeneron Pharmaceuticals Inc (REGN): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 869,074 US Dollar | 15 | 4 | 8 | 1 | 0 |
| #Shares | Short [%] | Short Ratio |
| 101.137.842 | 2,19 | 2,78 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Regeneron Pharmaceuticals Inc
Mitarbeiter 15.410
Handelsplatz NASDAQ
Ticker Symbol REGN
IPO Datum 1991-04-02
Adresse 777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707
Webseite https://www.regeneron.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Leonard S. Schleifer M.D., Ph.D. | Co-Founder, President, CEO & Co-Chairman |
| 2 | Dr. George D. Yancopoulos M.D., Ph.D. | Co-Founder, President, Chief Scientific Officer & Co-Chairman |
| 3 | Mr. Christopher R. Fenimore CPA | Executive VP of Finance & CFO |
| 4 | Mr. Joseph J. LaRosa J.D. | Executive VP, General Counsel & Secretary |
| 5 | Dr. Andrew J. Murphy Ph.D. | Executive VP of Research & Co-Chief Scientific Officer |
| 6 | Mr. Daniel P. Van Plew | Executive VP and GM of Industrial Operations & Product Supply |
| 7 | Mr. Rajesh Ahuja | Senior Vice President of Quality Assurance & Operations |
| 8 | Mr. Ryan Steinberger | Executive VP, Chief Digital & Technology Officer |
| 9 | Mr. Ryan Crowe | Senior Vice President of Investor Relations & Strategic Analysis |
| 10 | Ms. Melissa Lozner | Senior VP & Chief Compliance Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 8,85% | 7,41 Mrd. USD |
| 2 | Vanguard Capital Management, LLC | 6,44% | 5,39 Mrd. USD |
| 3 | Dodge & Cox | 4,73% | 3,96 Mrd. USD |
| 4 | State Street Corp | 4,70% | 3,93 Mrd. USD |
| 5 | Amvescap Plc. | 3,83% | 3,21 Mrd. USD |
| 6 | JPMorgan Chase & Co | 3,67% | 3,07 Mrd. USD |
| 7 | Vanguard Portfolio Management, LLC | 3,08% | 2,58 Mrd. USD |
| 8 | Franklin Templeton Inc | 2,69% | 2,25 Mrd. USD |
| 9 | Geode Capital Management, LLC | 2,55% | 2,14 Mrd. USD |
| 10 | Nuveen, LLC | 1,96% | 1,64 Mrd. USD |
| 11 | Loomis, Sayles & Company LP | 1,81% | 1,51 Mrd. USD |
| 12 | T. Rowe Price Associates, Inc. | 1,49% | 1,24 Mrd. USD |
| 13 | Morgan Stanley - Brokerage Accounts | 1,36% | 1,14 Mrd. USD |
| 14 | Bank of America Corp | 1,25% | 1,05 Mrd. USD |
| 15 | Wellington Management Company LLP | 1,23% | 1,03 Mrd. USD |
| 16 | NORGES BANK | 1,14% | 0,95 Mrd. USD |
| 17 | The Goldman Sachs Group Inc | 1,13% | 0,95 Mrd. USD |
| 18 | AQR Capital Management LLC | 1,09% | 0,92 Mrd. USD |
| 19 | Amundi | 0,98% | 0,82 Mrd. USD |
| 20 | Northern Trust Corp | 0,89% | 0,75 Mrd. USD |